 Reata Pharmaceuticals, Inc. NASDAQ:RETA Q3 2022 Results Conference Call November 8, 2022 8:30 AM ET Company Participants Warren Huff - Chief Executive Officer Manmeet Soni - President Colin Meyer - Chief Innovation Officer Seemi Khan - Chief Medical Officer Dawn Bir - Chief Commercial Officer Conference Call Participants Yigal Nochomovitz - Citigroup Madhu Kumar - Goldman Sachs Yatin Suneja - Guggenheim Charles Duncan - Cantor Fitzgerald Carter Gould - Barclays Annabel Samimy - Stifel Maurice Raycroft - Jefferies Operator Thank you for standing by, and welcome to the Reata Pharmaceuticals Third Quarter 2022 Financial Results and Update on Development Programs Conference Call. An audio recording of todays webcast will be available shortly after the call in the Investor section of Reatas website at reatapharma.com. 